Evidence map›Paper›PMID 41009667›Full record

ArticleInternational journal of molecular sciences2025

Exploring Oxidative Stress in Different Endometriosis Phenoptypes: Insights from Ovarian and Systemic Perspectives by the Study of SIRT3.

Anna Goday, Laura Valls-Roca, Marta Méndez, Yolanda Cívico, Meritxell Gràcia, Mariona Guitart-Mampel, Gemma Casals, Sara Peralta, Aina Borrás, Francisco Fàbregues and 9 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anna GodayAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0002-9733-5338
Laura Valls-RocaFaculty of Medicine and Health Sciences, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
Marta MéndezAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0002-4265-4411
Yolanda CívicoAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.
Meritxell GràciaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Villarroel 170, 08036 Barcelona, Spain.
Mariona Guitart-MampelFaculty of Medicine and Health Sciences, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
Gemma CasalsAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.
Sara PeraltaAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0002-1277-8659
Aina BorrásAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0002-3838-7920
Francisco FàbreguesAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.
Inés AgustíAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.ORCID 0000-0001-9459-4062
Yasmina BarralAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.
Cristina RosGynecology Department, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Universitat de Barcelona, 08036 Barcelona, Spain.
Maria Àngels MartínezInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Villarroel 170, 08036 Barcelona, Spain.
Mariona RiusGynecology Department, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Universitat de Barcelona, 08036 Barcelona, Spain.
Salvadora CívicoAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.
Gloria GarrabouFaculty of Medicine and Health Sciences, Universitat de Barcelona (UB), 08036 Barcelona, Spain.ORCID 0000-0001-8973-9933
Francisco CarmonaFaculty of Medicine and Health Sciences, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
Dolors ManauAssisted Human Reproduction Unit, Gynecology Service, Clinic Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, 08036 Barcelona, Spain.

Funding

Adamed (Poland) 10000
6 · The paper itself

Abstract

Endometriosis affects about 10% of reproductive-aged women, characterized by endometrial-like tissue outside the uterus, leading to chronic inflammation. The exact cause remains unknown, though genetic and epigenetic factors are increasingly recognized alongside traditional theories. The disease manifests in forms such as endometriomas, whether superficial or peritoneal, and deep infiltrating lesions, often causing chronic pain and infertility. Infertility affects nearly 50% of patients, requiring expensive treatments like in vitro fertilization. Oxidative stress plays a key role in endometriosis, with sirtuins, especially SIRT3, emerging as important regulators. SIRT3, located in mitochondria, helps manage oxidative stress and redox balance. Despite extensive research, no diagnostic biomarkers exist. This longitudinal study compares oxidative stress markers and SIRT3 levels in patients with different endometriosis types. While classic oxidative stress markers showed no significant differences, higher SIRT3 levels were observed in peripheral blood mononuclear cells of patients with deep endometriosis. Additionally, patients with prior surgeries had elevated SIRT3 levels, indicating a possible link between disease severity and SIRT3 expression. The findings suggest SIRT3 as a potential therapeutic target in endometriosis management.

Indexed as

EndometriosisOvaryOxidative StressSirtuin 3AdultBiomarkersFemaleHumansLeukocytes, MononuclearLongitudinal StudiesBiomarkersSIRT3 protein, humanSirtuin 3deep endometriosisendometriosisinfertilityin vitro fertilization (IVF)ovarian endometriomaoxidative stressSIRT3sirtuins

Identifiers

PMID41009667
PMCPMC12470309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.